Skip to content
healthcare.dev

Fulvestrant

NDC 62332-650, Fulvestrant, injection, from Alembic Pharmaceuticals Inc..

Product NDC
62332-650
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215077
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-650 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
62332-650-10623320650102 SYRINGE in 1 CARTON (62332-650-10) / 5 mL in 1 SYRINGE (62332-650-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b02915fe-6c44-48c1-aaeb-997ddc59a595
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=62332-650

Use it

Look up 62332-650 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-650 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.